Centene's second-quarter figures beat analysts' forecasts, yet the market reaction was muted as attention focused elsewhere. The shares fell up to 11% at the opening bell, marking the steepest decline since March, after management indicated that restoring profitability in Medicaid would require more time than initially anticipated.
The numbers on the surface look good. Centene raised its full-year guidance for profit per share of stock, known as adjusted EPS, to more than $4.80, up from a prior forecast of greater than $3.40. That is a big jump. However, roughly 50 cents per share of that upward guidance comes from non-recurring gains.
Get the market news that matters in a five-minute read with Market Briefs, our free daily newsletter
The real problem is Medicaid. Federal cuts to the program are expected to accelerate in 2027, and Centene has already lost more Medicaid members than it expected. CEO Sarah London put it plainly, saying the policy changes "will mute the full potential of margin recovery that we would want to see."
Centene is one of the largest managed care organizations in the United States, specializing in government-sponsored healthcare programs. The company's Medicaid business has been under pressure as states resume eligibility redeterminations after the pandemic, leading to enrollment losses that have been steeper than projected. These ongoing headwinds, combined with the scheduled federal funding reductions, mean that a full profit recovery may not materialize until after 2027.
Centene is not alone in feeling the squeeze. The Obamacare market, which the company also plays in heavily, is getting tougher. Centene lost about 2 million members in that business after it raised premiums and after the pandemic-era subsidies that kept coverage cheap expired.
Other insurers are reacting the same way. Molina Healthcare, another big player, reported worse-than-expected Obamacare results and said it plans to shrink that part of its business next year. Industry-wide, initial rate submissions indicate insurers will raise premiums by an average of 14%. A number of health plans have either reduced their presence or exited completely due to higher expenses, shrinking membership, the end of subsidies, and tighter regulatory oversight.
This is where the stock market and the real world meet. Companies like Centene are stuck between two forces: they need to charge enough to make money, but if they raise prices too much, they lose members. And when the government cuts funding on top of that, the math gets even harder.
Expectations were elevated heading into the report - Centene's stock had gained 56% year-to-date as of the prior Monday. When those hopes got pushed out a few years, investors hit the sell button. Baird analyst Michael Ha wrote that the results weren't far above "the increasingly bullish buy-side expectations embedded in the shares."
Join Market Briefs, our free daily newsletter, for a quick daily rundown of the markets
